In an early-stage clinical trial, the therapy nearly doubled the expected survival time of young patients. Still, experts ...
A study shows that high-grade glioma tumor cells harboring DNA alterations in the gene PDGFRA responded to the drug avapritinib, which is already approved by the United States Food and Drug ...
1d
News Medical on MSNPotential Targeted Therapy Results in Pediatric Brain Tumor ReductionScientists performed a first-ever clinical test of the therapy avapritinib in pediatric patients with high-grade glioma. They ...
A new therapy offers hope for treating pediatric brain tumors, targeting cancer cells while minimizing side effects for young ...
Health and Me on MSN4d
Blood-Brain Barrier Dysfunction Linked To Down SyndromeResearchers of a new study have discovered that DSRD patients showed signs of neuroinflammation and blood-brain barrier ...
For years, scientists studying brain aging have focused on proteins and DNA. But what if a crucial piece of the puzzlehas ...
High-grade glioma, a difficult-to-treat and aggressive form of pediatric and adult brain cancer, responded to FDA-approved avapritinib. | Drug Discovery And Development ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results